Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.65 HKD | +5.37% | +1.06% | -78.63% |
05-10 | Sirnaomics Ltd. Appoints Edward Yongxiang Wang as Executive Director | CI |
04-17 | Sirnaomics Receives US FDA Guidance on Trials for Squamous Cell Carcinoma Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-78.63% | 80.68M | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.88% | 21.93B | |
-12.15% | 22.34B | |
-5.43% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- 2257 Stock
- News Sirnaomics Ltd.
- Sirnaomics Receives US FDA Guidance on Trials for Squamous Cell Carcinoma Treatment